Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
P. V. Raninga, A. Lee, D. Sinha, L.-f. Dong, K. K. Datta, X. Lu, P. Kalita-de Croft, M. Dutt, M. M. Hill, N. M. Pouliot, H. Gowda, M. Kalimutho, J. Neuzil, K. K. Khanna
Marizomib inhibits primary tumor growth and reduces lung and brain metastases in pre-clinical triple-negative breast cancer models.
bioRxiv · Oct 11, 2019Cancer Biology